T2 Biosystems, Inc. TTOO Income Statement

T2 biosystems, inc. (TTOO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13	Jun'13
Product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	1,747	1,511	1,176	1,024	598	0	0	0	-	-	-	-	-	-
Research revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	2,333	2,670	2,970	2,695	2,214	0	0	0	-	-	-	-	-	-
Revenue:
Total revenue
9,095	8,335	7,058	7,847	9,974	10,500	10,369	9,011	6,036	4,666	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	4,080	4,181	4,146	3,720	2,813	0	0	0	-	-	-	-	0	0
Costs and expenses:
Cost of product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	6,872	5,611	4,546	2,767	1,742	0	0	0	-	-	-	-	-	-
Research and development
17,363	16,326	15,344	13,971	13,672	14,489	15,348	18,503	21,866	23,733	25,428	24,748	24,005	24,009	24,796	25,800	26,082	25,362	23,935	22,534	20,586	19,782	17,929	16,853	0	0	0
Selling, general and administrative
26,746	27,304	26,216	26,108	26,997	25,697	24,804	24,490	22,638	22,757	22,987	23,363	23,747	24,077	23,290	22,536	20,830	19,094	17,832	15,635	13,644	11,018	8,547	6,866	0	0	0
Total costs and expenses
61,155	60,393	60,343	57,960	57,188	55,590	56,231	58,136	58,178	58,518	56,308	55,792	55,225	54,958	53,697	52,882	49,677	46,196	42,597	38,170	34,231	30,800	0	0	0	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Loss from operations
-52,060	-52,058	-53,285	-50,113	-47,214	-45,090	-45,862	-49,125	-52,142	-53,852	-52,393	-51,901	-51,300	-50,878	-49,516	-48,736	-45,957	-43,383	-40,676	-37,298	-33,923	-30,681	-26,385	-23,508	0	0	0
Interest expense, net
-6,983	-7,348	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	-	-	-	-
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Other income, net
235	400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	12	0	0	0	-	-
Net loss and comprehensive loss
-58,808	-59,006	-60,114	-56,710	-53,387	-51,153	-54,197	-57,506	-60,638	-62,428	-58,784	-57,491	-56,081	-54,804	-52,287	-51,148	-48,097	-45,290	-42,334	-38,781	-35,089	-31,390	-26,956	-23,879	0	0	0
Comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-31,390	0	0	0	0	0
Net loss
-58,808	-59,006	-60,114	-56,710	-53,387	-51,153	-54,197	-57,506	-60,638	-62,428	-58,784	-57,491	-56,081	-54,804	0	0	0	-	-	-	-	-	0	0	0	0	0
Accretion of redeemable convertible preferred stock to redemption value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,570	0	0	0	-	-
Accretion of redeemable convertible preferred stock to redemption value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net loss applicable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-37,753	-35,960	-33,437	-31,513	0	0	0
Net loss per share — basic and diluted
-0.22	-0.29	-0.31	-0.35	-0.34	-0.34	-0.25	-0.32	-0.36	-0.51	-0.45	-0.50	-0.48	-0.48	-0.51	-0.58	-0.55	-0.56	-0.57	-0.54	-0.53	9.16	-0.71	-6.35	-6.25	-4.69	-4.95
Weighted-average number of common shares used in computing net loss per share — basic and diluted
68,637	47,896	45,424	44,427	44,282	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20,260	-	19,457	12,379	1,451	1,411	1,398	1,397
Product [Member]
Total revenue
5,058	5,327	5,084	5,125	5,071	4,805	4,821	4,342	3,857	3,440	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of product revenue
17,046	16,763	18,783	17,881	16,519	15,404	16,079	15,143	13,674	12,028	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research [Member]
Total revenue
-	563	742	1,934	4,574	5,695	5,548	4,669	2,179	1,226	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contribution [Member]
Total revenue
3,616	2,445	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-